We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-9.02%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.54B
AUM Growth
-$187M
Cap. Flow
+$195K
Cap. Flow %
0.01%
Top 10 Hldgs %
16.48%
Holding
333
New
25
Increased
139
Reduced
93
Closed
34

Top Sells

Rank Stock Value
1
DBD
Diebold Nixdorf Incorporated
DBD
+$18.1M
2
STKL
SunOpta
STKL
+$15.4M
3
MAGN
Magnera Corp
MAGN
+$13.9M
4
FCFS icon
FirstCash
FCFS
+$12.9M
5
KN icon
Knowles
KN
+$7.68M

Sector Composition

Rank Sector Weight
1 Industrials 19.53%
2 Technology 15.58%
3 Consumer Discretionary 15.16%
4 Healthcare 14.52%
5 Financials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEVA icon
76
CEVA Inc
CEVA
$1.08B
$5.28M 0.34%
284,493
+20,481
+8% +$377K
TFX icon
77
Teleflex
TFX
$5.98B
$5.09M 0.33%
40,963
+3,386
+9% +$453K
PF
78
DELISTED
Pinnacle Foods, Inc.
PF
$5.03M 0.33%
120,182
-3,528
-3% -$159K
ZD icon
79
Ziff Davis
ZD
$1.98B
$5.01M 0.32%
81,269
+6,713
+9% +$407K
LCII icon
80
LCI Industries
LCII
$2.65B
$4.65M 0.3%
85,208
+6,296
+8% +$355K
CLVS
81
DELISTED
Clovis Oncology, Inc.
CLVS
$4.6M 0.3%
50,008
+20,516
+70% +$1.78M
XYL icon
82
Xylem
XYL
$28.1B
$4.58M 0.3%
139,399
-3,217
-2% -$108K
EBS icon
83
Emergent Biosolutions
EBS
$248M
$4.41M 0.29%
154,850
+62,630
+68% +$2.06M
ENDP
84
DELISTED
Endo International plc
ENDP
$4.29M 0.28%
61,942
-1,597
-3% -$128K
TER icon
85
Teradyne
TER
$59.3B
$4.21M 0.27%
233,533
-7,545
-3% -$139K
NVDA icon
86
NVIDIA
NVDA
$5.42T
$4.19M 0.27%
6,794,440
-507,280
-7% -$274K
BBRG
87
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$4.08M 0.26%
362,251
+26,412
+8% +$335K
ATTU
88
DELISTED
Attunity Ltd
ATTU
$4.05M 0.26%
296,015
+19,475
+7% +$274K
NSR
89
DELISTED
Neustar Inc
NSR
$3.93M 0.25%
144,394
+12,138
+9% +$344K
SN
90
DELISTED
Sanchez Energy Corporation
SN
$3.86M 0.25%
627,711
-2,160
-0.3% -$14.5K
MTN icon
91
Vail Resorts
MTN
$5.3B
$3.83M 0.25%
36,630
+3,016
+9% +$326K
ESL
92
DELISTED
Esterline Technologies
ESL
$3.83M 0.25%
53,233
+4,388
+9% +$374K
BC icon
93
Brunswick
BC
$5.28B
$3.82M 0.25%
79,813
-2,256
-3% -$115K
FLIR
94
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$3.8M 0.25%
135,640
-4,035
-3% -$119K
BID
95
DELISTED
Sotheby's
BID
$3.74M 0.24%
116,972
-2,909
-2% -$111K
CLC
96
DELISTED
Clarcor
CLC
$3.68M 0.24%
77,217
-2,050
-3% -$116K
EW icon
97
Edwards Lifesciences
EW
$51.7B
$3.63M 0.23%
153,000
-4,020
-3% -$97K
MIDD icon
98
Middleby
MIDD
$6.08B
$3.55M 0.23%
33,711
+409
+1% +$47.1K
JNJ icon
99
Johnson & Johnson
JNJ
$625B
$3.52M 0.23%
37,740
FEIC
100
DELISTED
FEI COMPANY
FEIC
$3.48M 0.23%
47,638
+455
+1% +$35.9K

Similar funds

Rice Hall James & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Rice Hall James & Associates held 333 positions worth $1.54B, down 11% from $1.73B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Rice Hall James & Associates's Q3 2015 filing shows 25 new, 139 increased, 93 reduced and 34 closed positions. Its largest new stake was Pegasystems: 1,394,762 shares worth $17.2M. The largest sale was Diebold Nixdorf Incorporated, an estimated $18.1M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Rice Hall James & Associates's largest Q3 2015 buy was Pegasystems: 1,394,762 shares worth $17.2M.
  • Rice Hall James & Associates added most to Tetra Tech in Q3 2015, an estimated $18.3M increase.
  • Rice Hall James & Associates's biggest Q3 2015 reduction was AMN Healthcare, cutting an estimated $7.06M.
  • Rice Hall James & Associates fully exited Diebold Nixdorf Incorporated in Q3 2015, selling an estimated $18.1M.
  • Rice Hall James & Associates's ten largest holdings make up 16% of its $1.54B portfolio in Q3 2015.
  • Rice Hall James & Associates opened 25 new positions and closed 34 in Q3 2015.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $1.54B.

Based on Rice Hall James & Associates's 13F filing for Q3 2015, filed 30 Oct 2015.